Compare ENOV & ECPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ENOV | ECPG |
|---|---|---|
| Founded | 1995 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Fluid Controls | Finance Companies |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.8B |
| IPO Year | 2008 | 1999 |
| Metric | ENOV | ECPG |
|---|---|---|
| Price | $26.06 | $86.21 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | $47.38 | ★ $77.33 |
| AVG Volume (30 Days) | ★ 1.3M | 323.1K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 287.14 |
| EPS | N/A | ★ 3.86 |
| Revenue | N/A | ★ $1,768,802,000.00 |
| Revenue This Year | $6.36 | $4.53 |
| Revenue Next Year | $5.31 | $4.76 |
| P/E Ratio | ★ N/A | $22.85 |
| Revenue Growth | N/A | ★ 34.37 |
| 52 Week Low | $19.14 | $35.68 |
| 52 Week High | $34.28 | $94.60 |
| Indicator | ENOV | ECPG |
|---|---|---|
| Relative Strength Index (RSI) | 53.79 | 45.41 |
| Support Level | $21.02 | $77.69 |
| Resistance Level | $27.11 | $93.68 |
| Average True Range (ATR) | 1.49 | 2.67 |
| MACD | 0.15 | -0.77 |
| Stochastic Oscillator | 48.26 | 5.24 |
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
Encore Capital Group Inc is an international specialty finance company engaged in providing debt recovery solutions and other related services for consumers across a broad range of financial assets. It mainly purchases portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals to repay their obligations and work toward financial recovery. The company also provides debt servicing and other portfolio management services to credit originators for non-performing loans in Europe. It has only one reportable segment, debt purchasing and recovery. Geographically, the company generates maximum revenue from its business in the United States, followed by the United Kingdom, Europe, and other regions.